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Engineered nanoparticles (NPs) have been widely demonstrated to induce toxic effects to various cell types. In vitro cell exposure
systems have high potential for reliable, high throughput screening of nanoparticle toxicity, allowing focusing on particular
pathways while excluding unwanted effects due to other cells or tissue dosimetry. The work presented here involves a detailed
biologically based computational model of cellular interactions with NPs; it utilizes measurements performed in human cell culture
systems in vitro, to develop a mechanistic mathematical model that can support analysis and prediction of in vivo effects of NPs.
Themodel considers basic cellular mechanisms including proliferation, apoptosis, and production of cytokines in response to NPs.
This new model is implemented for macrophages and parameterized using in vitro measurements of changes in cellular viability
and mRNA levels of cytokines: TNF, IL-1b, IL-6, IL-8, and IL-10.Themodel includes in vitro cellular dosimetry due to nanoparticle
transport and transformation. Furthermore, the model developed here optimizes the essential cellular parameters based on in
vitro measurements, and provides a “stepping stone” for the development of more advanced in vivo models that will incorporate
additional cellular and NP interactions.
1. Introduction
In vitro testing of cellular responses to xenobiotics is an im-
portant alternative approach to animal experimentation in
the context of human health risk assessment. This approach
is supported by the 2007 National Research Council (NRC)
report, “Toxicity testing in the 21st century: a vision and a
strategy” [1], which called for a transformation of toxicity test-
ing froma systembased onwhole animal testing to one focus-
ing primarily on in vitromethods.This approach includes the
use of selected in vitro assays in cell culture systems for hazard
screening and development of quantitative structure activity
models, limited animal studies for understanding kinetics,
and the use of pharmacokinetic models for extrapolation of
results from in vitro to in vivo, between species, and across
sensitive populations [1]. The Tox21 initiative [2] forwarded
jointly by the National Toxicology Program (NTP) and the
Environmental Protection Agency (EPA) also recommends
the increased use of in vitro assays for human toxicity
assessment. Since the publication of the 2007 NRC report,
there has been a considerable research effort on replacing
experiments using animal in vivomodels with a combination
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Figure 1: Schematic representation of information flow between complementary approaches, in vitro, in vivo, and in silico, in a framework
aiming to support biological understanding of toxicodynamic processes in humans and model organisms.
of targeted cellular in vitro experiments and computational
modeling, to generate human risk estimates, thus saving
effort and time and reducing uncertainty in cross-species
scaling. Figure 1 shows a simplified schematic representation
of the complimentary relationship between in vitro and in
vivo approaches for both animals and humans. The entire
process involves multiple instances of information exchange
between complementary strategies to lead to a complete
understanding of human health risk assessment from envi-
ronmental xenobiotics like NPs. The work presented here
pertains to amodel that aims to improve the understanding of
toxic interactions occurring in an in vitro system, thus build-
ing an essential component of the framework of Figure 1,
which can be used for the development of in vivo assessments
in animals and in humans.
The twomajor steps involved in cellular interactions with
xenobiotics are cellular uptake (which includes adhesion to
the cell surface and internalization) and cellular immune
responses due to the entry of the xenobiotic [3].The immune
response becomes critical during exposure to nanoparticles
and might lead to cell apoptosis or altered cellular functions
in response to secondary stimuli.The inflammatory response
system in mammals consists of a series of cascading events
facilitated by several types of cells and protein mediators
such as cytokines and chemokines [4]. The major types of
lung cells involved in the inflammatory response system are
macrophages (Mph), dendritic cells, alveolar epithelial type
I and type II (AT1 and AT2) cells, and the various inflam-
matory cells such as poly-mono-nuclear neutrophils (PMNs),
lymphocytes, and eosinophils [5]. Xenobiotics can trigger
cytokine and chemokine production when in the local milieu
and once inside the cell. On release, these chemical mediators
signal the influx of more macrophages and inflammatory
cells into the lung from the blood circulation, inducing
further a cascade of events which comprise an inflammatory
response, leading to removal of the nanoparticles (NPs) due
to phagocytosis and endocytosis by the inflammatory cells
[6]. Such a response is expected to restore homeostasis after
removal of the xenobiotic chemical and replenishment of the
dead cells. Under normal circumstances, an inflammatory
response is tightly controlled by release of both pro- and
anti-inflammatorymediators [7]. However, in some cases, the
response might be unable to revert to homeostasis, leading to
tissue sepsis [7].
In the early stage of inflammation, elimination of the
xenobiotic (e.g., NPs) by phagocytosis is the priority of the
response system [8]. Macrophages (Mph) play a major role
in the phagocytic removal of NPs, after which they migrate
to the lymph glands through the lymphatic and blood
circulation system or may be transferred to the throat via the
mucociliary clearance system and swallowed or expectorated.
NPs are also endocytosed by other cells of the alveolar region.
Inside the cells, large quantities of reactive intermediates
(reactive oxygen and nitrogen) are produced in the early
stage to set up an appropriate response and neutralize the
xenobiotics [9]. However, excess production of reactive
intermediates also triggers secondary mechanisms which
might lead to cellular apoptosis [6]. As mentioned earlier, the
presence of NPs signals the influx of more phagocytic cells
to the alveolar region for removal of NPs, partly involving
release of cytokines and chemokines, which are produced
by cells such as Mph, immune cells (Imm), comprising
neutrophils, and lymphocytes in varying amounts [10]. As
inflammation progresses, there is an increase in the cell count
of the system due to influx of Mph and Imm and also an
increase in concentration of the chemical mediators. Inflam-
matory chemical mediators can be proinflammatory or anti-
inflammatory or both, depending on their concentration
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Figure 2: Cellular interaction, migration, and cytokine secretion of four cell types in the pulmonary alveolar subsystem for a proposed in
vivo toxicodynamic model.The diagram includes macrophages, alveolar type I and alveolar type II cells, and immune cells, including cell-cell
regulatory and signaling pathways.𝑅1,𝑅2, and so forth are the basal kinetic rates of the various cellular processes;𝑅
𝑖−𝑗
is the rate of regulation
of process 𝑅
𝑖
by the cell or chemical in CID 𝑗. All process and compartment IDs are listed on the right. (The diagram follows the standards
of the Systems Biology Graphical Notation (SBGN); see http://www.sbgn.org).
[11]. In essence, proinflammatory mediators (such as TNF-𝛼
and IL-6) upregulate and anti-inflammatory mediators (IL-
10) downregulate the inflammatory response. In ideal cases,
after the NPs have been removed from the system, the anti-
inflammatory response is expected to help restore the system
to homeostasis [11].This is accompanied by removal of apop-
totic cells, reduction in concentrations of proinflammatory
cytokines, and clearance of immune cells from the tissue by
migration or apoptosis [7]. Figure 2 summarizes the signaling
effects mediated by the various alveolar cells in response to
xenobiotic exposure.
Cellular dosimetry of nanoparticles in an in vitro cell
culture medium is often ignored but is of crucial importance
in estimating the actual number of particles reaching the
cells in question [12, 13]. Medium properties affecting dif-
fusion, sedimentation, agglomeration, and dissolution of the
particles cause appreciable changes in particle distribution in
the medium over time. Particle characteristics such as size,
shape, surface coating, density, and agglomeration state and
properties of themedium, such as density and viscosity, affect
particokinetics in fluid media and need to be considered
explicitly [14]. Aggregation of NPs in the culture medium
causes change in size and shape of the NPs, which affects the
cellular uptake of NPs. Dissolution of silver NPs leads to the
production of ionic silver which is a known oxidizing and
cytotoxic agent.
Mathematical modeling of cellular dynamics has been
accomplished mechanistically utilizing systems of ordinary
differential equations (ODEs) to simulate cellular processes
[15, 16].Themodel developed here combines the effects of NP
transformation processes and cellular dynamics and has been
implemented for macrophages comprising in vitro cultures.
Mathematical modeling of cellular responses to xenobiotics
requires estimation of a large number of parameters for the
particular cell types under consideration. In vitro toxico-
logical studies of the cellular response to xenobiotics allow
for a simplified system that excludes confounding factors
introduced by other cells and processes involved in tissue
4 Journal of Toxicology
Table 1: Properties of silver NPs used in the model.
NP Coating Core material Density (g/cm3) Mol. wt. Coating mol. wt Zeta potential (mV)
Ag20 Citrate Ag 10.49 108 258 −39.2
Ag50 Citrate Ag 10.49 108 258 −39.2
C20 Citrate Au 10.87 115.3 258 −44.3
P20 PVP Au 10.87 115.3 10000 −38.2
C110 Citrate Au 10.49 108.04 258 −45.2
P110 PVP Au 10.49 108.04 40000 −31.6
Source: nAg properties (for Ag20, Ag50) from Leo et al., 2013 [19]; nAg properties (for C20, P20, C110, and P110) from http://www.nanoComposix.com).
dosimetry. Assessments of risks due to NPs pose serious
challenges to the NRC paradigm, particularly in the area
of cellular dosimetry [17] and in the extrapolation to a
real human population [2]. Derivation of parameters for
such studies can be facilitated by modeling first the in vitro
case, in conjunction with parameter optimization based on
results of in vitro experiments. This information can provide
a foundation for subsequent in vivo modeling of cellular
responses in animal systems.
2. Methods
2.1. Modeling Transport and Transformation of Particles in
Culture Media. Particle interactions need to be considered
for in vitro systems to study toxic effects on biological media
as these interactions impact particle dosimetry to the cells,
affecting the actual number of particles that interact with
cells at any given time [17]. Particle agglomeration is also
an important process, especially for nanoparticles, whose
large surface area to volume ratio leads to an increased
tendency to agglomerate in order to reduce the overall surface
energy of the system. In an actual in vitro medium, the
processes of gravitational sedimentation, diffusion, agglom-
eration, and dissolution occur simultaneously. The first
two processes are particle transport processes and the
last two are particle transformation processes. A compre-
hensive model named ADSRM (agglomeration-diffusion-
sedimentation-reaction model) has been developed for this
purpose [18], to simultaneously quantify the in vitro evolution
of NPs with time, considering agglomeration, sedimentation,
and dissolution. The model has been implemented for citrate
and PVP (polyvinylpyrrolidone) coated NPs to estimate in
vitro dosimetry for the cell cultures. Nanoparticles denoted
by Ag20 and Ag50 are citrate-stabilized silver nanoparticles
produced according to Leo et al. [19]. The nanoparticles C20,
P20, C110, and P110 were obtained from (and physicochem-
ical properties were characterized by) the Nanotechnology
Characterization Laboratory (NCL,National Cancer Institute
at Frederick, SAIC-Frederick, Inc., Frederick, MD) under
NIEHS-NCL Agreement. PVP of two different molecular
weights were used as stabilizer, with 10 kD PVP present in
20 nmnAg and 40 kD PVP in 110 nmnAg. The properties of
the nAg used for the study are summarized in Table 1. For
in vitro cultures with cells, the nAg samples were diluted
in RPMI1640 supplemented with 10% pooled human AB
serum and sonicated in a Branson 3510 water bath sonicator
for 2 minutes prior to addition to the cell cultures. The
ADSRM uses the Direct Simulation Monte Carlo (DSMC)
method to simulate evolution of a group of NPs in a
medium and explicitly includes mutual collisions, diffusion,
settling, and reactions of NPs with other chemicals in the
medium. Reactions of coating chemicals like citrate and
PVP have also been included in the model. Dissolution has
been modeled as a surface-reaction controlled process and
is affected by the exposed surface area of the nAg which
changes due to oxidation of citrate [20] and dissolution of
PVP [21]. Sulfidation of nAg has been shown to be a major
process affecting silver precipitation in biological media [22].
Sulfidation might act as a potential detoxifying process by
removing silver ions from solution [23, 24]. Liu et al. [24] have
shown sulfidation to proceed via two mechanisms: direct,
involving surface oxysulfidation of silver nanoparticles by
sulfides, and indirect, involving precipitation of soluble silver
ions as silver sulfides. Both processes of sulfidation have
been included in the ADSRM to account for the presence of
sulfides in cell culturemedia, using kinetic rates of sulfidation
(both direct and indirect) from Liu et al. [24].
2.2. Mathematical Modeling of Inflammatory Response
2.2.1.Modeling Equations. Macrophages (Mph), alveolar type
I (AT1) and alveolar type II cells (AT2), and inflamma-
tory cells (Imm) are key components of the inflammatory
response system in the alveolar region of the lung.The cellular
compartments are responsible for the removal and intake of
NPs and production of anti- or proinflammatory chemical
mediators. In an in vitro system, the presence of only a
single cell type allows for the analysis of the effects due to
that specific type of cell, without interference of intercellular
signaling effects. Figure 3 shows the effects considered in
the model for macrophages (Mph). The model considers
macrophage proliferation and apoptosis and the production
of four key cytokines in response to uptake of nAg from the
culture media. For the in vitromodel, the process is designed
to start from the initial number of cells used in each sample
medium. The cellular count is controlled by their apoptosis
Journal of Toxicology 5
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Figure 3: Schematic representation of macrophage dynamics
involving proliferation, apoptosis, and cytokine secretion in vitro.
(Thediagram follows the standards of the SystemsBiologyGraphical
Notation (SBGN); see http://www.sbgn.org).
and proliferation. The proliferation of cells is assumed not to
be limited by the presence of nutrients in the medium.These
processes can be represented by the equations below:
𝑑𝑁
𝑑𝑡
= 𝑅Pro − 𝑅Apo, (1)
where 𝑅Pro is the rate of cellular proliferation and 𝑅Apo is the
rate of cellular apoptosis.
Cytokines TNF, IL-6, IL-1b, and IL-10 are considered to
be secreted by the cell in the in vitro culture at a basal rate
𝑅
𝑖
and to degrade at a rate 𝑘
𝑑,𝑖
. The production of cytokines
by cells is influenced by xenobiotics or cytokines present in
the environment. The regulation is modeled using Hill-type
kinetics. It is assumed here that the regulation is uniformover
each cell type. Consider
𝑑𝐶
𝑖
𝑑𝑡
= 𝑅
𝑖
(1 + 𝑓reg,𝑖) − 𝑘𝑑,𝑖𝐶𝑖,
𝑓reg,𝑖 = ∏
𝑖,𝑗
𝑓
𝑖−𝑗
,
(2)
where 𝑓
𝑖−𝑗
denotes the regulation effect of cytokine 𝑗 on
cytokine 𝑖. The regulation effects are modeled via Hill-type
equations as follows:
𝑓
𝑖−𝑗
=
𝐶
𝑛
𝑗
𝑥
𝑖−𝑗
+ 𝐶
𝑛
𝑗
, for upregulation
𝑓
𝑖−𝑗
=
𝑥
𝑖−𝑗
𝑥
𝑖−𝑗
+ 𝐶
𝑗
, for downregulation.
(3)
The power 𝑛 controls the strength of the regulation effect.
2.2.2. Cellular Uptake of Nanoparticles. NPs are taken up
by alveolar cells via endocytosis or phagocytosis. This phe-
nomenon plays a critical role in estimating exposure and fate
of NPs in the biological system as the alveolar epithelial cells
form the gateway to the circulatory system and hence to the
entire body. Lai et al. [25] showed that charcoalNPs are signif-
icantly taken up by type I cells, type II cells, andmacrophages.
Cellular uptake of particles is influenced by particle type, size,
and surface charge [26]. Cellular uptake has been considered
to be composed of two processes: delivery and adhesion
of NPs onto the cell and uptake of NPs by the cell via
phagocytosis. Adhesion of NPs onto the cell surface is a
function of particle size, surface zeta potential, and cell type.
Adhesion probability, 𝑘
𝑓,𝑚
, is modeled according to Su et al.
[26] as 𝑘
𝑓,𝑚
= 𝑘
𝑐,𝑚
𝜂
𝑜
𝜂
𝑒
((1 − 𝜖)/𝜖𝑑
𝑐
), where 𝜖 is the tissue
porosity for Mph, 𝑑
𝑐
is the cell diameter, 𝑘
𝑐
is a cell type
dependent parameter, and 𝜂
𝑜
, 𝜂
𝑒
are the relative affinities of
particle adhesion to the cell due to their size and surface
zeta potential, respectively. Values of porosity and average cell
diameter for Mph have been obtained from Clegg et al. [27]
and Morgan and Talbot [28]. 𝜂
𝑜
is a function of NP diameter
𝑑
𝑝
; the relation has been obtained for alveolar Mph from
Oberdo¨rster et al. [29]. 𝜂
𝑒
is a function of 𝜁, the surface zeta
potential of the NPs; the relation was obtained for alveolar
Mph fromTabata and Ikada [30].Mph phagocytosis has been
modeled by Michaelis-Menten kinetics, with phagocytosis
rate parameters estimated from Beduneau et al. [31]. The
uptake of NPs by cells is given by
𝑑𝑁NP
𝑑𝑡
= −𝑅NP,Mph, (4)
where 𝑅Mph = 𝑘𝑓,𝑚(𝑉𝑚𝑁/(𝐾𝑚 + 𝑁)) and 𝑘𝑓,𝑚 = 𝑘𝑐,𝑚((1 −
𝜖)/𝜖𝑑
𝑐
)𝜂
𝑜
𝜂
𝑒
, where 𝜂
𝑜
= 𝑓(𝑑
𝑝
), 𝜂
𝑒
= 𝑓(𝜁).
2.3. Cell Culture Measurements. Measurements of cell
viability were made with Cell Titer 96 Aqueous One Solution
Cell Proliferation Assay [MTS, (3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tet-
razolium)] with human alveolar macrophages as well as
with human monocyte-derived macrophages (MDMs),
incubated with different doses of 20 nm and 110 nmnAg for
24 hours.The alveolar macrophages are primary human cells,
cultured and exposed to nAg in serum free DCCM-1 media,
with approximately 100,000 cells/well. The experiment was
carried out in 96-well plates in a volume of 200𝜇L. The
human MDMs were incubated with nAg in RPMI1640
medium (supplemented with L-glutamine and 10% pooled
human AB serum) in a total volume of 1.5mL. The cytokine
study was carried out with human MDMs. NP solutions
were prepared as 2, 20, and 50𝜇g/mL and sonicated in a
Branson 3510 water bath sonicator for 2 minutes prior to
in vitro cell exposure. 0.75mL of the media was added to
the cells making the total volume 1.5mL. This resulted in
an actual NP dose of 1.5, 15, and 37.5 𝜇g to the cell medium
containing about 44,000 cells per well. Total RNA extracted
from exposed MDMs was analyzed by quantitative RT-PCR
as described by Sarkar et al. [32].
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Figure 4: Schematic showing the implementation of the ADSRM for citrate-stabilized nAg in an in vitro culture well, with the control volume
and the actual well shown as 1 and 2, respectively, along with an actual image (inset) of a Falcon 6-well plate used for in vitromeasurements
(figure reproduced fromMukherjee et al. [18] with permission) (diagram is not drawn to scale and is representative only).
Table 2: Parameter values used in the ADSRM implementation.
Parameter Value References\notes
Packing factor 0.637 Sterling et al. [37]
Fractal dimension 2.3 Hinderliter et al. [17]
Activation energy 33 × 103 J Zheludkevich et al. [38]
Rate constant for citrate oxidation 1.235 × 10−10mol/m3/sec Estimated from Zhang et al. 2011 [20]
Rate constant for direct sulfidation 0.018mM−1⋅min−1 Liu et al. 2011 [24]
Rate constant for indirect sulfidation 0.00016min−1 Liu et al. 2011 [24]
Mass transfer rate of O2 1.67 × 10
−6mol/m3/sec Estimated by Zhang et al. 2011 [20]
Saturation conc. of O2 8.96mg/L Zhang et al. 2011 [20]
Density of medium 1000 kg/m3 Density of water
Viscosity of medium 0.001 Pa-s Viscosity of water
3. Results and Discussions
3.1. ADSRM Simulation. The ADSRM was run for a time
period of 24 hours, using the NP properties summarized
in Table 1 and the parameter values summarized in Table 2.
The ADSRM model was implemented for a cell culture
plate simulating a Falcon 6-well plate, as shown in Figure 4.
Figure 5 shows the changes in nAg mean diameter and size
distribution over 24 hours. In the in vitro culture, the cells
reside at the bottom of the culture plate and consequently are
not exposed to the entire population of NPs in the medium.
Only the fraction of NPs which have settled (Figure 5(c))
interact with the cells. The figures show that the average NP
diameters increase due to agglomeration. Between 20 nm and
110 nmnAg, the larger nAg have a greater preference toward
settling, leading to a relatively higher dose for the cells at the
bottom of the culture plate.
3.2. In Vitro Cell Model Results. Results from the mathe-
matical model of the in vitro cell system described above
are presented and compared with in vitro measured values
performed for this purpose. The parameter values have been
summarized in Table 3. Cell viability was measured in vitro
for human alveolar macrophages using MTS assays. Figure 6
shows comparisons between model predictions and mea-
sured values for four doses of 20 and 110 nm citrate-coated
nAg. There is good agreement between model predictions
and measured values, except for the dose of 6.25 𝜇g/mL of
110 nmnAg for which the measurement shows an unusually
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Figure 5: Model predictions from ADSRM for transformation processes of 4 different types of nAg in cell culture media over 24 hours; (a)
mean diameter of all NPs in the medium over the time span of 24 hours, (b) mean diameter of NPs settled at the bottom of the culture plate,
(c) mass fraction of nAg settled, and (d) size distribution of nAg settled. ((a) and (c) reproduced fromMukherjee et al. [18] with permission).
Table 3: Optimized values of parameters for MDM in vitro cultures
(with reference for initial estimate).
Proliferative index 0.23 [39]
Apoptotic index 0.11 [39]
TNF production rate∗ 2.671 × 10−10 nmol/min [10]
IL-6 production rate∗ 7.0962 × 10−10 nmol/min [10]
IL-8 production rate∗ 4.34 × 10−8 nmol/min [10]
IL-10 production rate∗ 9.458 × 10−10 nmol/min [40]
∗Cytokine production rates represent the rate for 106 cells.
high value but also a correspondingly high error. Figure 7
shows a comparison between model predictions and mea-
sured values for proinflammatory cytokine (IL-1b, TNF-
𝛼, and IL-6) levels in the cell culture medium. Cytokine
mRNA levels were measured in cell culture medium with
human MDMs 4 hours after incubation with 20 and 50 nm
citrate-coated nAg. Model predictions and measured values
seem to agree well for IL-1b and TNF-𝛼; however the
model seems to consistently underestimate the level of IL-
6 cytokine. Figure 8 shows the same comparison for the
anti-inflammatory cytokine IL-10. Model predictions agree
well with measured values, except for the highest dose of
20 nmnAg, where the measured value shows a high degree
of uncertainty. Additionally, the model was executed with
andwithout the inclusion of theNP agglomeration-diffusion-
sedimentation-reaction model (ADSRM), to determine the
extent of effects due to in vitro cellular dosimetry of NPs.
Figure 9 shows a comparison between model predictions
with and without ADSRM-based adjustments along with
a comparison of measured values for the four different
8 Journal of Toxicology
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Figure 6: Comparison between model prediction and in vitro
measurement for human alveolarmacrophage cell viability, 24 hours
after incubation. Bars represent model predictions and squares and
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cytokines modeled. The results show a considerable increase
in the levels of proinflammatory cytokines and a decrease in
the anti-inflammatory cytokines when ADSRM is not con-
sidered. Absence of cellular dosimetry calculations presumes
a well-mixed culture medium, where all the particles come
into contact with the cells instantly, giving a proportionately
higher effect than what is observed in the measured values.
3.3. Discussion. The model was parameterized to obtain
values of rate constants for cell proliferation, apoptosis, and
cytokine secretion. The effect of NPs on cellular processes
was also parametrized. The parameters optimized in this
study can be used to support predictions in the context of
in vivo cellular inflammatory modeling which will consider
various cell types in physiological interactions and simulate
the actual alveolar microenvironment. In vivo modeling of
NP toxicity can be informed by the cellular parameters
estimated from this work but of course needs to include
other cellular interaction and signaling effects. Inflammatory
processes in vivo are composed of multiple cellular signaling
effects which regulate cytokine secretion and cellular migra-
tion in a tissue [4]. Figure 2 presents a diagram summa-
rizing the key signaling and regulatory processes occuring
in the alveolar subsystem involving type I cells, type II
cells, macrophages, and immune cells. Immune cells like
lymphocytes and neutrophils are recruited from the blood
stream at sites of inflammation. Macrophage dynamics are
also affected by complexities which were not considered
in this in vitro model. Macrophages are known to present
markedly different phenotypes in tissue systems, a fraction
of them being in a “resting” phase and others in an “active”
phase. They also demonstrate well known M1 and M2
Table 4: Equations constituting the mathematical framework for a
proposed in vivo cellular scale inflammatory pathway model.
Resting
macrophages
𝑑𝑁RMph
𝑑𝑡
= 𝑅Mig,RMph − 𝑅Act
Active
macrophages
𝑑𝑁Mph
𝑑𝑡
= 𝑅Act − 𝑅Elim,Mph − 𝑅Apo,Mph
Type I cells
𝑑𝑁AT1
𝑑𝑡
= 𝑅Pro,AT1 − 𝑅Apo,AT1
Type II cells
𝑑𝑁AT2
𝑑𝑡
= 𝑅Pro,AT2 − 𝑅Apo,AT2
Immune cells
𝑑𝑁Imm
𝑑𝑡
= 𝑅Mig,Imm − 𝑅Elim,Imm
NP uptake by Mph
𝑑𝑁NP,Mph
𝑑𝑡
= 𝑘f,Mph ⋅
𝑉Mph𝑁NP
𝐾Mph + 𝑁NP
NP uptake by AT1
𝑑𝑁NP,AT1
𝑑𝑡
= 𝑘f,AT1 ⋅
𝑉AT1𝑁NP
𝐾AT1 + 𝑁NP
NP uptake by AT2
𝑑𝑁NP,AT2
𝑑𝑡
= 𝑘f,AT2 ⋅
𝑉AT2𝑁NP
𝐾AT2 + 𝑁NP
TNF-𝛼 secretion
𝑑𝑀TNF
𝑑𝑡
= 𝑅TNF,Mph + 𝑅TNF,AT2 + 𝑅TNF,Imm
IL-6 secretion
𝑑𝑀IL6
𝑑𝑡
= 𝑅IL6,Mph + 𝑅IL6,AT1 + 𝑅IL6,AT2 + 𝑅IL6,Imm
IL-8 secretion
𝑑𝑀IL8
𝑑𝑡
= 𝑅IL8,Mph + 𝑅IL8,AT1 + 𝑅IL8,AT2 + 𝑅IL8,Imm
IL-10 secretion
𝑑𝑀IL10
𝑑𝑡
= 𝑅IL10,Mph+𝑅IL10,AT1+𝑅IL10,AT2+𝑅IL10,Imm
Chemokine
secretion
𝑑𝑀ChK
𝑑𝑡
= 𝑅ChK,Mph + 𝑅ChK,AT1 + 𝑅ChK,AT2
NP balance
𝑑𝑁NP
𝑑𝑡
= 𝑅NP,alv−𝑅NP,Mph−𝑅NP,AT1−𝑅NP,AT2−𝑅Elim
phenotypes [11] wherein they support proinflammatory and
anti-inflammatory actions, respectively. Various basal kinetic
rates and intercellular regulatory rates are depicted by circles
in Figure 2. Table 4 summarizes a mathematical framework
for implementation of the inflammatory pathway model
in vivo using parameter values and information from in
vitro models as described here. Macrophage and immune
cell recruitment, macrophage activation, cytokine secretion,
and various intercellular activation and inhibition processes
would be caused by NP exposure in vivo and these processes
will bemodeled using differential equations shown inTable 4.
These processes would also be affected by parameters such
as 𝑘
𝑓
and 𝑘
𝑐
which in turn are functions of NP and cell
properties as has been discussed in detail in Section 2.2.2.
The regulation processes are expected to follow the basic
scheme shown for macrophages in Equations (2) and (3)
but would be more complex, involving additional regulatory
parameters. In vivo modeling of cellular dynamics would
also require a complete whole body toxicokinetic model to
predict NP translocation and retention utilizing in vivo data
in rodents [33–35]. Particularly, the rate 𝑅NP,alv shown in
Table 4would capture the rate of translocation ofNPs into the
alveolar region after inhalation. Figure 1 shows a simplified
representation of a framework utilizing information from
various in vitro and in vivo studies in conjunction with
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Figure 7: Comparison of model predictions and measured values of proinflammatory cytokine levels in culture medium after 4 hours for
human MDMs with different doses of 20 nm (a) and 50 nm (b) nAg in vitro. Bars represent model predictions and squares and error bars
represent in vitromeasurements.
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Figure 8: Comparison of model predictions and measured values of anti-inflammatory cytokine (IL-10) levels in culture medium after 4
hours for human MDMs with different doses of 20 nm (a) and 50 nm (b) nAg in vitro. Bars represent model predictions and squares and
error bars represent in vitromeasurements.
in silico models like the one described in this article, to sup-
port better understanding of nanoparticle toxicodynamics. A
combination of in vitro and in vivomodels alongwith suitable
in vitro-in vivo extrapolation can help utilize information
from high throughput in vitro toxicological studies and
incorporate such information in building detailed predictive
models [36] offering novel insights into complex biological
processes.
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